Last updated on December 2019

ASCEND GO-2: Study of RVT-1401 for the Treatment of Patients With Active Moderate to Severe Graves' Ophthalmopathy ( GO )


Brief description of study

The purpose of the current study is to assess the efficacy and safety/tolerability of three dose regimens of RVT-1401 in the treatment of active, moderate to severe GO patients. In addition, the study is designed to characterize the effect of RVT-1401 exposure on reduction in anti-TSHR IgG

Clinical Study Identifier: NCT03938545

Find a site near you

Start Over